Company & Sponsor Intelligence
Göteborg University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials7
Recruiting1
Completed6
Countries1
Therapeutic footprint
adhdautismneurodevelopmental_otherother_neurologypain_neuropathyschizophreniastroke
Indexed studies
NCT04505072RCT of PR-ESSENCE - a Problem Solving Model for Youth With Challenging Behavior in Special (SiS) Treatment Homes
neurodevelopmental_other · SwedenNA
neurodevelopmental_other · SwedenNA
NCT0287212912-years Follow-up on 166 Female Patients With Fibromyalgia or Chronic Widespread Pain
pain_neuropathy · SwedenCOMPLETED
pain_neuropathy · SwedenCOMPLETED
NCT06368687TRANPAS - TReating Anorexia Nervosa Plus Autism Spectrum
autism · NA
autism · NA
NCT03182283Person-Centered Psychosis Care: An Educational Intervention
schizophrenia · SwedenNA
schizophrenia · SwedenNA
NCT03694340Optimization of Cochlear Implant MAP-parameters in Children
other_neurology · SwedenNA
other_neurology · SwedenNA
NCT01219309Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
adhd · PHASE3
adhd · PHASE3
NCT02889939High-intensity Training in an Enriched Environment in Late Phase After Stroke
stroke · SwedenNA
stroke · SwedenNA
Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →